Cargando…
Emerging therapeutic agents for genitourinary cancers
The treatment of genitourinary malignancies has dramatically evolved over recent years. Renal cell carcinoma, urothelial carcinoma of the bladder, and prostate adenocarcinoma are the most commonly encountered genitourinary malignancies and represent a heterogeneous population of cancers, in both his...
Autores principales: | Zarrabi, Kevin, Paroya, Azzam, Wu, Shenhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727406/ https://www.ncbi.nlm.nih.gov/pubmed/31484560 http://dx.doi.org/10.1186/s13045-019-0780-z |
Ejemplares similares
-
Novel therapies in genitourinary cancer: an update
por: Chu, David, et al.
Publicado: (2008) -
New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
por: Zarrabi, Kevin, et al.
Publicado: (2017) -
Therapeutic Vaccines for Genitourinary Malignancies
por: Dutcher, Giselle M. A., et al.
Publicado: (2018) -
Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues
por: Da, Lin-Cui, et al.
Publicado: (2022) -
Evaluation and Management of Genitourinary Emergencies in Patients with Cancer
por: Lipe, Demis N., et al.
Publicado: (2021)